| Application no. and date | 17762648.8 (espacenet) (Federated) (European Patent Register), 20170309 | | Patent/reg. no. and date | DK/EP 3426254, 20230607 | | Publication date | 20190116 | | Priority no. and date | US 201662306147 P, 20160310 | | EP pub. no. and date |
EP 3426254 20190116 | | Effective date | | | Applicant/owner | Lutris Pharma Ltd., 27 Habarzel St.
6971039 Tel Aviv, IL | | Applicant ref. no. | | | Inventor | SHELACH, Noa, 21 Meridor
6941173 Tel Aviv, IL | | Representative | | | Opponent | | | IPC Class | A61K 31/167 (2006.01) , A61K 31/404 (2006.01) , A61K 31/4375 (2006.01) , A61K 31/44 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/506 (2006.01) , A61K 31/517 (2006.01) , A61K 31/519 (2006.01) , A61K 31/52 (2006.01) , A61P 17/00 (2006.01) | | Title | USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS | | Int. application no. | IL2017050301 | | Int. publication no. | WO2017154001 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
